ABCL |
AbCellera Biologics Inc. |
Sep 20, 2024 |
2 |
$152K |
4 |
Sep 24, 2024 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
May 31, 2024 |
2 |
$152K |
4 |
Jun 3, 2024 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
Feb 26, 2024 |
2 |
$152K |
4 |
Feb 27, 2024 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
Jan 14, 2024 |
1 |
$0 |
4 |
Jan 16, 2024 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
Nov 23, 2023 |
2 |
$152K |
4 |
Nov 27, 2023 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
Aug 24, 2023 |
2 |
$152K |
4 |
Aug 25, 2023 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
May 26, 2023 |
2 |
$152K |
4 |
May 30, 2023 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
Feb 22, 2023 |
2 |
$152K |
4 |
Feb 23, 2023 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
Dec 1, 2022 |
1 |
$0 |
4 |
Dec 5, 2022 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
Nov 18, 2022 |
2 |
$152K |
4 |
Nov 21, 2022 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
Aug 18, 2022 |
2 |
$152K |
4 |
Aug 22, 2022 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
May 18, 2022 |
2 |
$152K |
4 |
May 19, 2022 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
Feb 22, 2022 |
2 |
$152K |
4 |
Feb 25, 2022 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
Dec 31, 2021 |
3 |
$0 |
5 |
Feb 3, 2022 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
Dec 7, 2021 |
1 |
$0 |
4 |
Dec 9, 2021 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
Nov 18, 2021 |
2 |
$3.37M |
4 |
Nov 22, 2021 |
Chief Executive Officer, Director, 10%+ Owner |
ABCL |
AbCellera Biologics Inc. |
Jun 9, 2021 |
2 |
-$145M |
4 |
Jun 10, 2021 |
Chief Executive Officer, Director, 10%+ Owner |